COVID-19 is associated with oxidative stress, peripheral hyper inflammation, and
neuroinflammation, especially in individuals with a more severe form of the disease. Some …

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread
globally, it became evident that the SARS-CoV-2 virus infects multiple organs including the …

SARS-CoV-2, the novel coronavirus infection has consistently shown an association with
neurological anomalies in patients, in addition to its usual respiratory distress syndrome …

Telemedicine has been at the mainstay of patient care by offsetting the decline in outpatient
visits during the Coronavirus disease 2019 (COVID-19) while providing critical patient …

Neurologic impairment persisting months after acute severe SARS-CoV-2 infection has
been described because of several pathogenic mechanisms, including persistent systemic …

Despite the international scientific community's commitment to improve clinical knowledge
about coronavirus disease 2019 (COVID‐19), knowledge regarding molecular details …

Seizures are a common presenting symptom during viral infections of the central nervous
system (CNS) and can occur during the initial phase of infection (“early” or acute …

The SARS-CoV-2 virus, first reported in December 2019 in China, is the causative agent of
the current COVID-19 pandemic that, at the time of writing (1 November 2020) has infected …

Microglia are the resident immune cells of the central nervous system contributing
substantially to health and disease. There is increasing evidence that inflammatory microglia …

The gut microbiota undergoes significant alterations in response to viral infections,
particularly the novel SARS-CoV-2. As impaired gut microbiota can trigger numerous …